CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

Photocure ASA: Results for the second quarter of 2026

EarningsHexvix®/Cysview®Neutral
AI Analysis

Summary

Photocure ASA reported Q2 2026 revenues of NOK 140.0 million for Hexvix®/Cysview®, a modest increase from NOK 135.6 million in Q2 2025, with adjusted EBITDA of NOK 27.2 million.

Financial Highlights

Revenue

NOK 140.0 million

Importance:3/10
Sentiment:
0.10
earningsQ2 2026revenue growthEBITDA
Related Companies

Read the original article

Published by PR Newswire Pharma on July 29, 2026 6:29 AM

Read Original